Levin VA - Search Results

1

Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.

Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Lang FF, et al. Among authors: levin va. Neuro Oncol. 2002 Oct;4(4):268-77. doi: 10.1093/neuonc/4.4.268. Neuro Oncol. 2002. PMID: 12356357 Free PMC article.

2

Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, Jaeckle KA, Yung WK, Buys SS, Bruner JM, Townsend JJ, Davis R, Sawaya R, Kyritsis AP. Puduvalli VK, et al. Among authors: levin va. Oncology. 2003;65(3):259-66. doi: 10.1159/000074479. Oncology. 2003. PMID: 14657600

3

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.

Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, Liu V, Mehta MP, Nicholas MK, Prados M; North American Brain Tumor Consortium. Puduvalli VK, et al. Among authors: levin va. J Clin Oncol. 2004 Nov 1;22(21):4282-9. doi: 10.1200/JCO.2004.09.096. J Clin Oncol. 2004. PMID: 15514370 Free PMC article. Clinical Trial.

4

Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status.

Groves MD, Puduvalli VK, Conrad CA, Gilbert MR, Yung WK, Jaeckle K, Liu V, Hess KR, Aldape KD, Levin VA. Groves MD, et al. Among authors: levin va. J Neurooncol. 2006 Oct;80(1):83-90. doi: 10.1007/s11060-006-9160-y. Epub 2006 Apr 25. J Neurooncol. 2006. PMID: 16639492 Clinical Trial.

5

Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.

Puduvalli VK, Giglio P, Groves MD, Hess KR, Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H, de Groot JF, Ritterhouse MG, Ictech SE, Yung WK. Puduvalli VK, et al. Among authors: levin va. Neuro Oncol. 2008 Apr;10(2):216-22. doi: 10.1215/15228517-2007-060. Epub 2008 Feb 26. Neuro Oncol. 2008. PMID: 18314417 Free PMC article. Clinical Trial.

6

Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.

Walbert T, Gilbert MR, Groves MD, Puduvalli VK, Yung WK, Conrad CA, Bobustuc GC, Colman H, Hsu SH, Bekele BN, Qiao W, Levin VA. Walbert T, et al. Among authors: levin va. J Neurooncol. 2011 Apr;102(2):273-80. doi: 10.1007/s11060-010-0313-7. Epub 2010 Jul 23. J Neurooncol. 2011. PMID: 20652724 Free PMC article.

7

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR; MD Anderson Community Clinical Oncology Program; Brain Tumor Trials Collaborative. Penas-Prado M, et al. Among authors: levin va. Neuro Oncol. 2015 Feb;17(2):266-73. doi: 10.1093/neuonc/nou155. Epub 2014 Sep 19. Neuro Oncol. 2015. PMID: 25239666 Free PMC article. Clinical Trial.

8

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M. Levin VA, et al. J Neurooncol. 2006 Jul;78(3):295-302. doi: 10.1007/s11060-005-9098-5. Epub 2006 Apr 25. J Neurooncol. 2006. PMID: 16636750 Clinical Trial.

9

Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme.

Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK, Levin VA. Groves MD, et al. Among authors: levin va. J Clin Oncol. 2002 Mar 1;20(5):1383-8. doi: 10.1200/JCO.2002.20.5.1383. J Clin Oncol. 2002. PMID: 11870183 Clinical Trial.

10

13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.

See SJ, Levin VA, Yung WK, Hess KR, Groves MD. See SJ, et al. Among authors: levin va. Neuro Oncol. 2004 Jul;6(3):253-8. doi: 10.1215/S1152851703000607. Neuro Oncol. 2004. PMID: 15279718 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters